It was suggested that these ten hub biomolecules may be significant novel molecular signatures in stroma targeted cancer treatment. 3.4.
← all excerpts
Targeting the tumor stroma: integrative analysis reveal GATA2 and TORYAIP1 as novel prognostic targets in breast and ovarian cancer.
1
—
—